Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
17.59
+0.31 (1.79%)
At close: Dec 20, 2024, 4:00 PM
17.20
-0.39 (-2.22%)
After-hours: Dec 20, 2024, 4:21 PM EST
Entrada Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 215.23 | 129.01 | - | - | - | - |
| Cost of Revenue | 120.19 | 99.88 | 66.61 | - | - | - |
| Gross Profit | 95.04 | 29.13 | -66.61 | - | - | - |
| Selling, General & Admin | 37.26 | 32.29 | 30.64 | 15.2 | 5.57 | 3.61 |
| Research & Development | - | - | - | 35.93 | 21.1 | 8.22 |
| Operating Expenses | 37.26 | 32.29 | 30.64 | 51.13 | 26.67 | 11.82 |
| Operating Income | 57.78 | -3.16 | -97.25 | -51.13 | -26.67 | -11.82 |
| Interest & Investment Income | 18.64 | 15.22 | 2.63 | 0.04 | 0.16 | 0.45 |
| Other Non Operating Income (Expenses) | - | - | - | - | - | 6.27 |
| EBT Excluding Unusual Items | 76.42 | 12.06 | -94.62 | -51.08 | -26.5 | -5.1 |
| Gain (Loss) on Sale of Assets | - | - | - | -0.07 | -0.02 | - |
| Pretax Income | 76.42 | 12.06 | -94.62 | -51.16 | -26.52 | -5.1 |
| Income Tax Expense | 21.47 | 18.74 | - | - | - | - |
| Net Income | 54.95 | -6.69 | -94.62 | -51.16 | -26.52 | -5.1 |
| Net Income to Common | 54.95 | -6.69 | -94.62 | -51.16 | -26.52 | -5.1 |
| Shares Outstanding (Basic) | 35 | 33 | 31 | 6 | 1 | 1 |
| Shares Outstanding (Diluted) | 36 | 33 | 31 | 6 | 1 | 1 |
| Shares Change (YoY) | 9.14% | 5.61% | 399.27% | 467.09% | 18.45% | - |
| EPS (Basic) | 1.55 | -0.20 | -3.02 | -8.16 | -24.00 | -5.47 |
| EPS (Diluted) | 1.55 | -0.20 | -3.02 | -8.16 | -24.00 | -5.47 |
| Free Cash Flow | -17.46 | 134.19 | -96.67 | -55.44 | -27.89 | -11.43 |
| Free Cash Flow Per Share | -0.49 | 4.06 | -3.09 | -8.85 | -25.23 | -12.25 |
| Gross Margin | 44.16% | 22.58% | - | - | - | - |
| Operating Margin | 26.85% | -2.45% | - | - | - | - |
| Profit Margin | 25.53% | -5.18% | - | - | - | - |
| Free Cash Flow Margin | -8.11% | 104.01% | - | - | - | - |
| EBITDA | 61.3 | -0.32 | -95.35 | -50.01 | -26.34 | -11.72 |
| EBITDA Margin | 28.48% | -0.25% | - | - | - | - |
| D&A For EBITDA | 3.52 | 2.84 | 1.9 | 1.12 | 0.33 | 0.1 |
| EBIT | 57.78 | -3.16 | -97.25 | -51.13 | -26.67 | -11.82 |
| EBIT Margin | 26.85% | -2.45% | - | - | - | - |
| Effective Tax Rate | 28.09% | 155.45% | - | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.